This study provides suggestive evidence that rare, additional, potentially protein-altering variants in PKD1 can improve ADPKD disease progression prediction, an important concern for ADPKD patients and physicians, at a population level across cohorts. This evidence concerns the gene PKD1 and autosomal dominant polycystic kidney disease.